ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Drug or electroshock treatments for depression appear to work by encouraging formation of new neurons, but the mechanism of action has been unclear, until now. Yale University's Ronald S. Duman and Jennifer L. Warner-Schmidt have found evidence that these treatments work by increasing production of vascular endothelial growth factor (VEGF) in the brain (Proc. Natl. Acad. Sci. USA 2007, 104, 4647). The researchers determined that VEGF promotes formation of new neurons in rats dosed with antidepressant drugs or treated with electroshock therapy. The growth factor is best known for supporting the development of new cells that form blood vessels. Duman and Warner-Schmidt observed that treatments for depression increase the number of these cells in the brain as well. VEGF's dual role therefore may explain a long-suspected link between depression and heart disease. The findings could lead to the development of new antidepressant drugs that mimic VEGF.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter